Endogenex is a startup based in the United States, 2 tracked investors.
Endogenex is a startup based in the United States. Brouky records 2 investors associated with the company.
Endogenex develops a novel pulsed electric field (PEF) device, the pulsENDO system, which is designed to reset the metabolic signaling in the small intestine to improve blood glucose control for people living with type 2 diabetes. The system is currently investigational and evaluated in clinical studies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.